newsfilter
← Latest News
Business Wire·

Epizyme to Participate in Upcoming Healthcare Conferences in March

Epizyme, (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies against novel epigenetic targets, today announced its participation in two investor conferences in March. Cowen